Cancer - Cancer PHGKB - 2

Specific PHGKB|Cancer|PHGKB

What's New

Last Posted: Nov 25, 2019

---

• Counseling young women with early breast cancer on fertility preservation. 
  Ter Welle-Butalid M E Elena et al. Journal of assisted reproduction and genetics 2019 Nov
• People with genetic condition should be given aspirin daily to slash their risk of colorectal cancer 
  Denton Daily, November 24, 2019
• Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib 
  JAMA Network Open, November 22, 2019
• Machine Learning Algorithm for Genome-Derived Prediction of Tumor Type 
  ASCO Post, November 2019
• Biomarker-Driven Oncology Clinical Trials: Key Design Elements, Types, Features, and Practical Considerations 
  C Hu et al, JCO Precision Oncology, October 2019
• Communication and Decision Making for Individuals with Inherited Cancer Syndromes 
  NCI, November 2019
• Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass. 
  Oliveira Douglas Nogueira Perez et al. PloS one 2019 (11) e0225249
• Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. 
  Hellmann Matthew D et al. The New England journal of medicine 2019 Nov (21) 2020-2031
• Study Suggests Repurposed Drugs Might Treat Aggressive Lung Cancer 
  NIH Director's Blog, November 19, 2019
• The mutational footprints of cancer therapies 
  O Pich et al, Nature Genetics, November 18, 2019
• Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer 
  H Sarvas et al, JNCI, November 2019
• Can skin cancer diagnosis be transformed by AI? 
  A Esteva et al, Lancet Digital Health, November 2019
• Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care 
  A Penson et al,JAMA Oncology, November 14, 2019
• Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer 
  T Mukama, et al. JAMA Oncology, November 14, 2019
• Toward Risk-Stratified Breast Cancer Screening: Considerations for Changes in Screening Guidelines 
  GL Gierach et al, JAMA Oncology, November 14, 2019